Filing Flows › BioScience Health Innovations (BHIC) › R&D spending
BioScience Health Innovations (BHIC) R&D spending by quarter
BioScience Health Innovations' R&D spending was $71K in Q2 2026 (second quarter 2026), +42% from Q1 2026. Over the last 4 quarters it ranged from $9K (Q2 2025) to $71K (Q2 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $71K | +42% | +664% |
| Q1 2026 | $50K | +154% | — |
| Q3 2025 | $20K | +112% | — |
| Q2 2025 | $9K | — | — |
Q2 2026 at a glance
BioScience Health Innovations, Q2 2026: revenue $1.0M (-41% year over year), operating margin -21.0%, net loss $186K, operating cash flow −$542K. The chart follows the revenue to costs, profit and cash.
Questions
What is BioScience Health Innovations' R&D spending?
BioScience Health Innovations' R&D spending was $71K in Q2 2026 (second quarter 2026), +42% from Q1 2026.
How has BioScience Health Innovations' R&D spending changed?
Over the last 4 quarters it ranged from $9K (Q2 2025) to $71K (Q2 2026).
Q2 2026 results → · How BioScience Health Innovations makes money →